Dr Cristina Smolenschi

- Spécialité
- Oncologue médical, expert estomac, colon, foie et pancréas
- Hôpital
- Gustave Roussy (Villejuif)
- Derniers articles
-
- Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients. (9 févr. 2025)
- A phase I clinical trial of intrahepatic artery delivery of TG6002 in combination with oral 5-fluorocytosine in patients with liver-dominant metastatic colorectal cancer. (9 janv. 2025)
- Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases. (1 nov. 2024)
- KRAS, a New Target for Precision Medicine in Colorectal Cancer? (12 oct. 2024)
- Oxaliplatin-induced peripheral neuropathy with hepatic arterial versus intravenous infusion in metastatic colorectal cancer. (16 sept. 2024)